Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Published in: Indian Journal of Hematology and Blood Transfusion 1/2016

01-06-2016 | Case Report

Avascular Necrosis of Head of Femur in Dyskeratosis Congenita - A Rare Presentation

Authors: Mukand Lal, Manoj Thakur, Sandeep Kashyap

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2016

Login to get access

Abstract

Avascular necrosis of head of femur is a rare presentation in Dyskeratosis Congenita (DC). Aplastic anaemia, increased susceptibility to infections and fatal pulmonary complications often complicate the clinical scenario in these patients leading to short life span and difficulty in performing surgical interventions. The diagnosis initially and subsequent management by total hip replacement posed a great challenge. To our knowledge this is the first case report of any intervention in form of total hip Arthroplasty done in DC. At 5 years of follow up the patient is asymptomatic with no radiographic signs of loosening or lysis.
Literature
1.
2.
Cole HN, Rauschkolb JC, Toomey J (1930) Dyskeratosis congenital with pigmentation, dystrophia unguis and leukokeratosisoris. Arch Dermatol Syphilol 21:71–95CrossRef
3.
Engmann MF (1926) A unique case of reticular pigmentation of the skin with atrophy. Arch Dermatol Syphilol 13:685–687CrossRef
4.
Knight S, Vulliamy T, Copplestone A, Gluckman E, Mason P, Dokal I (1998) Dyskeratosis Congenita (DC) Registry: identification of new features of DC. Br J Haematol 103:990–996CrossRefPubMed
5.
Inoue S, Mekanik G, Mahallati M, Zuelzer WW (1973) Dyskeratosis congenital with pancytopenia: another constitutional anemia. Am J Dis Child 126:389–396CrossRefPubMed
6.
Sorrow JM, Hitch JM (1963) Dyskeratosiscongenita: first report of its occurrence in a female and a review of the literature. Arch Dermatol 88:340CrossRefPubMed
7.
Steier W, Van Voolen GA, Selmanowitz VJ (1972) Dyskeratosis congenita: relationship to Fanconi’sanemia. Blood 39:510PubMed
8.
De Boeck Kris, Degreef H, Verwilghen R, Corbeel L, M Casteels-Van Daele (1981) Thrombocytopenia: first symptom in a patient with dyskeratosis congenita. Pediatrics 67:898–903PubMed
9.
Davidson HR, Connor JM (1988) Dyskeratosis congenita. J Med Genet 25(843–84):6
10.
Womer Richard, Clark Joseph E, Wood Pamela, Sabio Hernan, Kelly Thaddeus E (1983) Dyskeratosis congenita: two examples of this multisystem disorder. Pediatrics 71:603–609PubMed
11.
Kalb RE, Grossman ME, Hutt C (1986) Avascular necrosis of bone in dyskeratosis congenita. Am J Med 80:511–513CrossRefPubMed
12.
Hong-Yan Du, Pumbo Elena, Manley Peter, Field Joshua J, Bayliss Susan J, Wilson David B, Mason Philip J, Bessler Monica (2008) Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene. Blood 111(3):1128–1130
13.
Marrone A, Dokal I (2004) Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer. Expert Rev Mol Med 26:1–3
14.
15.
Alter BP, Baerlocher GM, Savage SA, Chanock SJ et al (2007) Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood 110(5):1439–1447CrossRefPubMedPubMedCentral
16.
Scoggins RB, Prescott KS, Asher GH et al (1971) Dyskeratosis congenita with Fanconi-type anemia: investigations of immunologic and other defects. Clin Res 19:409
17.
Erduran E, Hacisalihoglu S, Ozoran Y (2003) Treatment of dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor and erythropoietin. J Pediatr Hematol Oncol 25(4):333–335CrossRefPubMed
18.
Lombardi AV, Mallory TH, Cuckler JM et al (2004) Mid-term results of a polyethylene-free metal-on-metal articulation. J Arthroplasty 19:42CrossRefPubMed
19.
Willert HG, Buchhom GH, Fayyazi A et al (2005) Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints. A clinical and histomorphological study. J Bone Joint Surg Am 87:28CrossRefPubMed
20.
Hart AJ, Skinner JA, Winship P et al (2009) Circulating levels of cobalt and chromium from metal-on-metal hip replacement are associated with CD8 +  T-cell lymphopenia. J Bone Joint Surg Br 91:835CrossRefPubMed
Metadata
Title
Avascular Necrosis of Head of Femur in Dyskeratosis Congenita - A Rare Presentation
Authors
Mukand Lal
Manoj Thakur
Sandeep Kashyap
Publication date
01-06-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-015-0511-8

Other articles of this Special Issue 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Go to the issue

Images

“Red Hand Syndrome” Due to Cytarabine in a Case of Mantle Cell Lymphoma

Case Report

Methimazole Induced Total Myeloid Aplasia with Delayed Recovery Despite Granulocyte Colony Stimulating Factor (G-CSF): Marrow Progenitor Recovery Kinetics

Correspondence

Obstructive Uropathy as an Initial Presentation of Primary Myelofibrosis: Case Report and Review of Literature

Case Report

Misdiagnosis of Bone Metastasis Cancer After Using Adefovir Dipivoxi in a Hepatitis B Patient with Fanconi Syndrome

Case Report

Concomitant Presence of Two Distinct Clones of Chronic Lymphocytic Leukemia and Plasma Cell Myeloma in a Patient

Correspondence

Antiphospholipid Antibodies in Indian Women with Spontaneous, Recurrent Fetal Loss
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits